28th - 29th October 2021

3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our MarketsandMarkets 3rd Annual Cell & Gene Therapy Manufacturing Virtual Conference Cell culture & Bioprocessing.
 

We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 28th - 29th October 2021.

Learn from the leading experts of the industry about strategies, technologies and innovations in the area of bioprocessing of cell-gene therapies.

WHAT TO EXPECT
Key Highlights
  • Cell culture through dimensional process
  • Lentiviral bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • CMC considerations for NK cells
  • Supply chain and regulatory issues
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Scott Burger

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC
William Janssen

William Janssen

Consultant
Cell & Gene Therapy Consulting LLC

William Janssen

Consultant
Cell & Gene Therapy Consulting LLC
Mahendra Rao

Mahendra Rao

Chief Executive Officer
panCella

Mahendra Rao

Chief Executive Officer
panCella
Janet Rothberg

Janet Rothberg

Development Manager
CCRM

Janet Rothberg

Development Manager
CCRM
Devyn Smith

Devyn Smith

Chief Operations Officer (COO) and Head of Strategy
Sigilon, Inc

Devyn Smith

Chief Operations Officer (COO) and Head of Strategy
Sigilon, Inc
Tiffany Rau

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals
S.H. Popma

S.H. Popma

Ph.D, Creative Cell Therapies, Founder
SHP BioConsulting, Pennsylvania

S.H. Popma

Ph.D, Creative Cell Therapies, Founder
SHP BioConsulting, Pennsylvania
PAST EVENT GALLERY